Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nirman Agri GeneticsNSE:NIRMAN -1.46%85 EBITDA Margin % is 10.44% as of Sep. 2025, which is 21% below its 10-year median of 13.28. GuruFocus rates NSE:NIRMAN with a GF Score™ of 85/100 and a GF Value™ of ₹858.05 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 248 Agriculture companies, Nirman Agri Genetics ranks better than 58.06% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Nirman Agri Genetics EBITDA Margin % Related Terms
Nirman Agri Genetics EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Nirman Agri Genetics's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:NIRMAN vs CTVA, CF, MOS: EBITDA Margin % Comparison
For the Agricultural Inputs subindustry, Nirman Agri Genetics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nirman Agri Genetics EBITDA Margin % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Nirman Agri Genetics's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Nirman Agri Genetics's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nirman Agri Genetics (NSE:NIRMAN) has a EBITDA Margin % of 10.44% as of Sep. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nirman Agri Genetics and its competitors. This is 21% below median its historical median of 13.28. Over the past decade, Nirman Agri Genetics' EBITDA Margin % has ranged from 3.04 to 25.57. According to the industry distribution chart, Nirman Agri Genetics ranks #104 out of 248 companies in the Agriculture industry, placing it in the top 41.9%.
Is Nirman Agri Genetics' EBITDA Margin % too high?
Nirman Agri Genetics' current EBITDA Margin % of 10.44% is 21% below median its 10-year median of 13.28. Over the past 10 years, this metric has ranged from a low of 3.04 to a high of 25.57. The Agriculture industry median EBITDA Margin % is 9.63. Nirman Agri Genetics' value of 10.44% is 8.4% above this industry median. Based on the distribution chart, Nirman Agri Genetics ranks #104 out of 248 companies in the Agriculture industry, which is above the industry midpoint. Overall, Nirman Agri Genetics has a GF Score™ of 85/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nirman Agri Genetics' EBITDA Margin % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Nirman Agri Genetics ranks #104 out of 248 companies for EBITDA Margin %. This puts Nirman Agri Genetics in the upper half of its industry. The industry median EBITDA Margin % is 9.63. Nirman Agri Genetics' value of 10.44% is 8.4% above this benchmark. Historically, Nirman Agri Genetics' own EBITDA Margin % has ranged from 3.04 to 25.57 over the past decade. While the company's 10-year median is 13.28 vs. the industry median of 9.63, Nirman Agri Genetics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Agriculture company?
The median EBITDA Margin % among Agriculture companies is 9.63, based on 248 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nirman Agri Genetics's current EBITDA Margin % of 10.44% is 8.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nirman Agri Genetics and its competitors. For the Agriculture industry, the median EBITDA Margin % is 9.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nirman Agri Genetics's current EBITDA Margin % is 10.44%, which is 21% below median its own 10-year median of 13.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nirman Agri Genetics stock overvalued right now?
Based on GuruFocus' analysis, Nirman Agri Genetics (NSE:NIRMAN) is currently considered Possible Value Trap. The stock's GF Value™ is ₹858.05, compared to a current price of ₹40.45 — trading 95.3% below its estimated fair value. The current EBITDA Margin % is 10.44%, which is 21% below median its 10-year median of 13.28 and 8.4% above the Agriculture industry median of 9.63. Nirman Agri Genetics' overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Nirman Agri Genetics (NSE:NIRMAN), the current EBITDA Margin % is 10.44% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nirman Agri Genetics (NSE:NIRMAN) Overvalued in 2026?
Based on GuruFocus' analysis, Nirman Agri Genetics stock appears to be undervalued.
The current stock price of ₹40.45 is trading 95.3% below its estimated GF Value™ of ₹858.05.
GuruFocus considers Nirman Agri Genetics to be Possible Value Trap.
Key valuation signals for NSE:NIRMAN:
EBITDA Margin %: 10.44% (21% below median its 10-year median of 13.28)
GF Value™: ₹858.05 vs. price of ₹40.45 (95.3% below fair value)
Industry Position: 8.4% above the Agriculture median (#104 of 248)
No single metric tells the full story. See the NSE:NIRMAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nirman Agri Genetics Ltd is an organized Agri-Input company in India. It is in the business of production, processing, and marketing of high-quality hybrid seeds, pesticides, and bio-organic. These processes are used for different crops like corn, sunflower, cotton, paddy, grain sorghum, and others. It is engaged in the business of Agriculture Industry, Manufacturing & Processing of seeds. Its geographical segments include Revenue within India includes sales to customers located within India and Revenue outside India includes sales to customers located outside India including Export Benefits or Incentives.
85GF Score
Get the complete analysis for NSE:NIRMAN
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NIRMAN has been successfully added to your 
